X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Elder Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ADCOCK INGRAM
Jun-14
ELDER PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs380363-   
Low Rs188262-   
Sales per share (Unadj.) Rs491.2107.8-  
Earnings per share (Unadj.) Rs-3.2-27.2-  
Cash flow per share (Unadj.) Rs14.4-22.5-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.584.6-  
Shares outstanding (eoy) m20.54168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.9 20.0%   
Avg P/E ratio x-89.3-11.5 777.4%  
P/CF ratio (eoy) x19.7-13.9 -142.3%  
Price / Book Value ratio x0.83.7 20.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83352,659 11.1%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,1793,305 65.9%   
Avg. sales/employee Rs ThNM4,239.5-  
Avg. wages/employee Rs ThNM769.9-  
Avg. net profit/employee Rs ThNM-1,068.3-  
INCOME DATA
Net Sales Rs m10,08918,200 55.4%  
Other income Rs m257127 201.3%   
Total revenues Rs m10,34618,327 56.4%   
Gross profit Rs m-792-3,154 25.1%  
Depreciation Rs m361786 46.0%   
Interest Rs m2,756493 559.1%   
Profit before tax Rs m-3,653-4,305 84.9%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125269 46.5%   
Profit after tax Rs m-65-4,586 1.4%  
Gross profit margin %-7.8-17.3 45.3%  
Effective tax rate %-3.4-6.2 54.8%   
Net profit margin %-0.6-25.2 2.6%  
BALANCE SHEET DATA
Current assets Rs m9,24013,330 69.3%   
Current liabilities Rs m9,9987,500 133.3%   
Net working cap to sales %-7.532.0 -23.4%  
Current ratio x0.91.8 52.0%  
Inventory Days Days46111 41.8%  
Debtors Days Days60124 48.4%  
Net fixed assets Rs m10,1247,770 130.3%   
Share capital Rs m20685 243.4%   
"Free" reserves Rs m5,5820-   
Net worth Rs m7,73414,285 54.1%   
Long term debt Rs m4,8895,020 97.4%   
Total assets Rs m22,88226,986 84.8%  
Interest coverage x-0.3-7.7 4.2%   
Debt to equity ratio x0.60.4 179.9%  
Sales to assets ratio x0.40.7 65.4%   
Return on assets %11.8-15.2 -77.5%  
Return on equity %-0.8-32.1 2.6%  
Return on capital %22.3-19.8 -112.6%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,7541,554 756.6%  
From Investments Rs m-561-477 117.5%  
From Financial Activity Rs m-6,7624,556 -148.4%  
Net Cashflow Rs m4,4325,633 78.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5 Rs / ZAR

Compare ELDER PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: LUPIN LTD  FULFORD INDIA  CADILA HEALTHCARE  J.B.CHEMICALS  PFIZER  



Today's Market

From Urjit Patel to Shaktikanta Das; What Lies Ahead?(Podcast)

The week gone by saw Sensex plunge from 700 points to rise by over 600 points. With a volatile and eventful week, it was a challenge keeping up with the news every day.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - DIVIS LABORATORIES COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS